Monica Binaschi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3-ITD-Mutant Acute Myeloid Leukaemia.
Journal: Journal of cellular and molecular medicine
Published: August 05, 2024
Elacestrant in ER+, HER2- Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 22, 2024
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway.
Journal: Frontiers in oncology
Published: August 27, 2023
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Journal: Breast cancer research and treatment
Published: March 22, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
Journal: Breast cancer research and treatment
Published: August 10, 2022
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia.
Journal: Cells
Published: October 24, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors.
Journal: Molecular cancer therapeutics
Published: July 10, 2018
Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.
Journal: Cell death & disease
Published: December 01, 2015
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.
Journal: Bioorganic & medicinal chemistry letters
Published: October 31, 2014
MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.
MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.
Journal: Neoplasia (New York, N.Y.)
Published: May 16, 2013
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.
Journal: Bioorganic & medicinal chemistry letters
Published: March 08, 2013
Last Updated: 09/26/2026